Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases

PURPOSE: Intravenous (IVIG) and subcutaneous (SCIG) immunoglobulin infusions are widely used for the treatment of patients with primary immunodeficiency (PID) worldwide. This prospective, multicenter, open-label, single-arm Phase III study evaluated the efficacy, tolerability, and safety of IgPro20...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanegane, Hirokazu, Imai, Kohsuke, Yamada, Masafumi, Takada, Hidetoshi, Ariga, Tadashi, Bexon, Martin, Rojavin, Mikhail, Hu, Wilson, Kobayashi, Midori, Lawo, John-Philip, Nonoyama, Shigeaki, Hara, Toshiro, Miyawaki, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937544/
https://www.ncbi.nlm.nih.gov/pubmed/24504846
http://dx.doi.org/10.1007/s10875-013-9985-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937544/
https://www.ncbi.nlm.nih.gov/pubmed/24504846
http://dx.doi.org/10.1007/s10875-013-9985-z

Ejemplares similares